Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 3373 of 6351
-
Migraine drug trial for kids halted early – what we know
Symptom relief Stopped earlyThe reason for this study is to see if lasmiditan is safe and effective in children aged 6 to 17 with migraine. The study will last up to 20 weeks and may include up to 4 visits.
Phase 3 • Sponsor: Eli Lilly and Company • Aim: Symptom relief
Last updated Sep 04, 2026 00:00 UTC
-
Cancer drug ixazomib tested as potential MS treatment
Disease control Recruiting nowThe study seeks to investigate safety and efficacy of ixazomib (NINLARO), a proteasome inhibitor, in multiple sclerosis (MS). Participants will receive either ixazomib capsules or placebo capsules for up to 24 months.
Phase 1 • Sponsor: Queen Mary University of London • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Can we predict who wakes up? new study seeks answers
Knowledge-focused Recruiting nowThe study aims to identify factors that predict the medium and long-term outcome of patients with disorders of consciousness (DOC) undergoing early neurological rehabilitation. In this prospective, observational study, 130 DOC patients are going to be included (36 months). At st…
Sponsor: BDH-Klinik Hessisch Oldendorf • Aim: Knowledge-focused
Last updated Jun 26, 2026 19:11 UTC
-
Could a common arthritis drug ease tough myasthenia gravis?
Disease control CompletedThis is a 6 month study that will evaluate the efficacy of 5mg tofacitinib tablet taken twice a day in patients with refractory myasthenia gravis. Twenty adult participants will receive a four month treatment of tofacitinib followed by elution for one month.
Early phase 1 • Sponsor: Huashan Hospital • Aim: Disease control
Last updated Jun 26, 2026 17:36 UTC
-
Remote fitness program aims to keep cancer patients healthy while social distancing
Symptom relief CompletedTrial Phase: Phase III: Interventional Trial: Virtual clinics to deliver universal interventions to maintain and improve physical health, nutritional state and psychological wellbeing in people with cancer who are following social distancing guidance: A COVID-19 targeted trial. …
Sponsor: University Hospital Southampton NHS Foundation Trust • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC
-
New Drug-Coated membrane targets sarcoma after surgery
Disease control CompletedThis is an open label, first-in-man clinical trial to assess safety and tolerability of CEB-01 PLGA membrane in patients with recurrent or locally advanced retroperitoneal soft tissue sarcoma after surgery. The trial will be conducted in 3 dose-escalation cohorts (3 patients eac…
Phase 1 • Sponsor: CEBIOTEX • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Heart bypass drug showdown: which pill keeps arteries open longest?
Disease control CompletedThe Pilot study will be a single-center, randomized, open-label, active-controlled trial. After CABG surgery using Radial Artery Grafts (RA-CABG) and signing the informed consent, all patients will be screened according to the inclusion and exclusion criteria. Estimated 150 patie…
Phase 4 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
New pill could replace eye injections for Diabetes-Related vision loss
Disease control Recruiting nowThis is an open label dose-escalation study to evaluate the safety and treatment benefits of MS-553 in treatment-naive diabetic retinopathy patients with central involved macular edema. Fifteen subjects with diabetic macular edema will be enrolled into each of three dose cohorts …
Phase 1 • Sponsor: Shenzhen MingSight Relin Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Light and touch therapies tested for COVID-19 recovery
Symptom relief CompletedObjective: To compare low-level laser therapy and myofascial release in reducing inflammation and functional recovery in critically ill COVID-19 patients with 3-month home-based telerehabilitation assessment. Participants: One hundred two COVID-19 patients aged 45-60 years rando…
Sponsor: Beni-Suef University • Aim: Symptom relief
Last updated Jun 27, 2026 08:14 UTC
-
Shockwave showdown: which therapy eases heel pain best?
Symptom relief OngoingInflammation of the plantar fascia is known as plantar fasciitis and is commonly seen in active or overweight individuals. It can be treated via conservative or surgical therapies. Extracorporeal shockwave therapy has shown promise in the treatment of plantar fasciitis. Several s…
Sponsor: Hospital for Special Surgery, New York • Aim: Symptom relief
Last updated Jun 27, 2026 12:25 UTC
-
Apple watch helps heart patients get fit in new study
Symptom relief CompletedThe influence of an individualized sports program on dilated cardiomyopathy patients will be investigated in a randomized, prospective intervention study. 300 patients with dilated cardiomyopathy are included and examined over a period of 13 months. All participants will receive …
Sponsor: University Hospital Heidelberg • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Robotic suits and spinal zaps help paralyzed veterans take steps
Disease control CompletedSpinal cord injury (SCI) leads to several health-related consequences often linked to reduced levels of physical activity. Direct stimulation of the spinal cord, either through implanted devices or surface stimulation, has been combined with intense physical therapy assisted trea…
Phase 2 • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Scientists hunt for clues to stop Late-Life depression from coming back
Knowledge-focused OngoingLate-life depression (LLD) is associated with disability, increased risk for cognitive decline and dementia, elevated suicide risk, and greater all-cause mortality. These outcomes are related to depression being a recurrent disorder, with repeated episodes over a patient's lifeti…
Sponsor: University of Illinois at Chicago • Aim: Knowledge-focused
Last updated Jun 26, 2026 14:22 UTC
-
New eye implant could replace drops after retina surgery
Symptom relief Recruiting nowThis study will assess the control of inflammation at days 1, 7, 14, and 21 days following the vitreoretinal surgical procedure analyzing two randomized study arms: Intracanalicular dexamethasone insert group or topical steroid drop group. Patients must be 18 years of age and ol…
Phase 4 • Sponsor: The Cleveland Clinic • Aim: Symptom relief
Last updated Jul 31, 2026 00:00 UTC
-
New antibody drug targets Hard-to-Treat cancers in first human trial
Disease control Recruiting nowIn this first-in-human, muticenter, non-randomized, open-label, standard 3+3 dose escalation Phase I study encompasses 5 parts (Part 1-5). The purpose of this FIH study is to evaluate the safety and tolerability profile of CBA-1205.
Phase 1 • Sponsor: Chiome Bioscience Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Brain training and exercise combo shows promise for mild memory loss
Symptom relief CompletedThe study aiming to investigate the efficacy, safety, and potential mechanism of a multimodal intervention on cognitive function in individuals with MCI or the cognitive normal elderly living in a community. The recruited elderly aged 50-75 years with normal cognitive function or…
Sponsor: Huashan Hospital • Aim: Symptom relief
Last updated Jun 26, 2026 17:10 UTC
-
Could a single pill before surgery cut opioid use after kidney stone treatment?
Symptom relief CompletedThis is a randomized, placebo-controlled, double-blinded study examining the use of perioperative pregabalin in ureteroscopy with stent placement. Ureteroscopy is typically performed for kidney or ureteral stones, but may be performed for other reasons such as for the diagnosis a…
Phase 2/3 • Sponsor: University of Missouri-Columbia • Aim: Symptom relief
Last updated Jun 27, 2026 07:57 UTC
-
Can your genes predict fatty liver complications?
Knowledge-focused Recruiting nowNAFLD is most frequently linked to excess adiposity, insulin resistance and cardiometabolic risk factors, it has become the leading cause of liver disease worldwide, and is associated with increased mortality due to multiple causes. HFC has a strong genetic component and the inve…
Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC
-
Malaria drugs under watch: resistance study in kenya
Knowledge-focused CompletedThis implementation study evaluated the health systems feasibility, economic costs, and stakeholder acceptability of deploying multiple first-line therapies (MFTs) that were of the artemisinin-based combination therapies (ACTs) type, for uncomplicated malaria in Western Kenya. Th…
Sponsor: Strathmore University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC
-
Home chemo shot study could free myeloma patients from hospital trips
Symptom relief Recruiting nowThis study is to see if the standard of care subcutaneous injection of bortezomib can safely be administered at home by the patient or caregiver. All tests and assessments are based on standard of care procedures.
Phase 2 • Sponsor: AHS Cancer Control Alberta • Aim: Symptom relief
Last updated Jun 27, 2026 08:04 UTC